SEC Filings for Ayala Pharmaceuticals, Inc.
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2019-01-14
View Filing
DEF 14A - Other definitive proxy statements
Form Type: DEF 14A
Filing Date: 2019-01-11
View Filing
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form Type: 10-K
Filing Date: 2019-01-11
View Filing
SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors
Form Type: SC 13G/A
Filing Date: 2018-12-28
View Filing
PRE 14A - Other preliminary proxy statements
Form Type: PRE 14A
Filing Date: 2018-12-28
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2018-12-13
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2018-10-26
View Filing
25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Form Type: 25-NSE
Filing Date: 2018-10-18
View Filing
SC 13G - Statement of Beneficial Ownership by Certain Investors
Form Type: SC 13G
Filing Date: 2018-09-14
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2018-09-11
View Filing
